Send me a link:

*Text messaging rates may apply.

 Dow Up 0.13% Nasdaq Down 0.10%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
36.11 0.91(2.46%) Jul 28, 3:59PM EDT
Prev Close:37.02
Open:37.07
Bid:23.52 x 100
Ask:37.48 x 100
1y Target Est:39.00
Beta:0.97
Earnings Date:Aug 12 - Aug 13 (Est.)
Day's Range:35.56 - 37.65
52wk Range:20.02 - 42.50
Volume:635,224
Avg Vol (3m):1,102,120
Market Cap:2.70B
P/E (ttm):15.31
EPS (ttm):2.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MYGNDown 2.46%2.70B
ABT64.48B

Key Statistics

Forward P/E (1 yr):16.87
P/S (ttm):3.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :2.39
Quarterly EPS Est (Jun-14) :0.46
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):1.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback